GI
CDLX icon

GAMCO Investors’s Cardlytics CDLX Stock Holding History

GAMCO Investors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,615
Closed -$152K – 890
2022
Q3 		$152K Hold
1,615
– – ﹤0.01% 849
2022
Q2 		$360K Sell
1,615
-45
-3% -$15.1K ﹤0.01% 743
2022
Q1 		$913K Sell
1,660
-100
-6% -$60.4K 0.01% 627
2021
Q4 		$1.16M Sell
1,760
-35
-2% -$26.8K 0.01% 600
2021
Q3 		$1.51M Sell
1,795
-5
-0.3% -$5.07K 0.01% 557
2021
Q2 		$2.29M Sell
1,800
-100
-5% -$113K 0.02% 500
2021
Q1 		$2.08M Sell
1,900
-100
-5% -$132K 0.02% 504
2020
Q4 		$2.85M Sell
2,000
-305
-13% -$325K 0.03% 421
2020
Q3 		$1.63M Sell
2,305
-30
-1% -$21.8K 0.02% 497
2020
Q2 		$1.63M Buy
2,335
+900
+63% +$520K 0.02% 486
2020
Q1 		$502K Sell
1,435
-100
-7% -$70.8K 0.01% 655
2019
Q4 		$965K Sell
1,535
-50
-3% -$24.4K 0.01% 614
2019
Q3 		$531K Hold
1,585
– – ﹤0.01% 704
2019
Q2 		$412K Buy
1,585
+40
+3% +$8.01K ﹤0.01% 767
2019
Q1 		$256K Buy
+1,545
New +$251K ﹤0.01% 776

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

GAMCO Investors's CDLX Position: Q4 2022 in Review

GAMCO Investors sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 1,615 shares — an estimated $152K sold.

GAMCO Investors first reported a position in CDLX in Q1 2019 and held it in 15 quarters. The position peaked at $2.85M in Q4 2020. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • GAMCO Investors reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • GAMCO Investors sold 1,615 Cardlytics shares in Q4 2022, an estimated $152K.
  • GAMCO Investors first reported a position in Cardlytics in Q1 2019 and held it in 15 quarters.
  • GAMCO Investors's Cardlytics position peaked at $2.85M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.